The Challenges and Opportunities in Vietnam's Vaccine Supply

The Challenges and Opportunities in Vietnam's Vaccine Supply

Introduction:
The issue of vaccine supply in Vietnam has been a topic of concern in recent years. The country has faced various obstacles, including outdated pricing and lengthy approval processes. However, amidst these challenges, there have been some positive developments. This article will explore the current state of Vietnam's vaccine supply, highlight the potential for technological advancements, and discuss the need for self-sufficiency in vaccine production.

Current Challenges in Vaccine Supply:
The current state of vaccine supply in Vietnam presents several hurdles. The pricing of vaccines remains outdated, and the lengthy approval process further exacerbates the problem. While efforts have been made to streamline the approval process, as suggested by Bà Nhị Hà, a quicker turnaround time is necessary to meet the demand. Despite these efforts, as of December 2023, vaccines are still not readily available, and the required procedures are yet to be completed.

Positive Developments:
Amidst the challenges, there have been some positive developments in Vietnam's vaccine supply. POLYVAC successfully exported one million measles vaccines to India, with plans to export to Bangladesh and Iran in the near future. Additionally, Vietnam is among the countries that have received technology transfer for the production of mRNA vaccines, similar to the COVID-19 vaccine developed by Moderna. This technology transfer opens up opportunities for Vietnam to research and produce new generation vaccines to meet domestic demands and for export.

The Need for Self-Sufficiency in Vaccine Production:
The issue of vaccine security has been highlighted by a World Bank report, which sheds light on the concerning state of vaccine production in Vietnam. Companies like Vabiotech, Ivac, Polyvac, and Davac operate with limited resources, including infrastructure, personnel, and investment. Their products are primarily intended for the National Expanded Immunization Program, with prices that have remained unchanged for 15 years. Consequently, these companies struggle to cover the costs of raw materials, labor, and technology depreciation. The annual demand for vaccines remains relatively stable, leading to underutilized production capacities and financial losses.

Actionable Advice:

1. Streamline approval processes: The government should prioritize reducing the lengthy approval process for vaccines, allowing for quicker distribution and availability. This will ensure that vaccines reach the public in a timely manner, especially during times of crisis.

2. Invest in research and development: To enhance vaccine production capacities, it is crucial for Vietnam to invest in research and development. This will enable the country to adopt new technologies, improve production efficiency, and develop new vaccines that cater to evolving healthcare needs.

3. Implement market-based pricing: Updating the pricing of vaccines to reflect market conditions can help incentivize vaccine manufacturers and ensure their financial sustainability. Market-based pricing will enable companies to cover costs and invest in technology advancements, ultimately improving vaccine supply in the country.

Conclusion:
Vietnam's vaccine supply has faced numerous challenges, from outdated pricing to lengthy approval processes. However, positive developments, such as successful vaccine exports and technology transfers, provide opportunities for improvement. To overcome these challenges and ensure a secure vaccine supply, streamlining approval processes, investing in research and development, and implementing market-based pricing are essential steps. By taking these actions, Vietnam can enhance its vaccine production capacities, meet domestic demands, and potentially become a significant exporter of vaccines.